Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

27.60 -0.36 (-1.29%)
Streaming Delayed Price Updated: 10:31 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 Next >
OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook
Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s revenue... 
Via StockStory
Topics Economy World Trade
Exposures Supply Chain Tariff
3 Russell 2000 Stocks Walking a Fine Line
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
3 Hated Stocks Skating on Thin Ice
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Earnings Scheduled For February 6, 2025
Via Benzinga
Assessing Omnicell: Insights From 4 Financial Analysts
Via Benzinga
2 Healthcare Stocks with Promising Prospects and 1 to Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Beyond The Numbers: 4 Analysts Discuss Omnicell Stock
Via Benzinga
Why Omnicell (OMCL) Shares Are Trading Lower Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 17.5% in the afternoon session after the company reported weak first-quarter 2025 results, which featured full-year EPS and EBITDA guidance... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Omnicell’s (NASDAQ:OMCL) Q1 Sales Top Estimates But Stock Drops
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s... 
Via StockStory
Beyond The Numbers: 6 Analysts Discuss Omnicell Stock
Via Benzinga
What 5 Analyst Ratings Have To Say About Omnicell
Via Benzinga
Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results tomorrow morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and... 
Via StockStory
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and... 
Via StockStory
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may have... 
Via StockStory
What Analysts Are Saying About Omnicell Stock
Via Benzinga
3 Healthcare Stocks Skating on Thin Ice
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Astrana Health (ASTH) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare services company Astrana Health will be reporting results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to expect. 
Via StockStory
Waystar (WAY) Reports Q4: Everything You Need To Know Ahead Of Earnings
Healthcare technology company Waystar Holding (NASDAQ:WAY) will be reporting results tomorrow morning. Here’s what to look for. 
Via StockStory
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next... 
Via StockStory
Earnings To Watch: Omnicell (OMCL) Reports Q4 Results Tomorrow
Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. 
Via StockStory
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%). 
Via Benzinga
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
Via Benzinga
Exposures Fossil Fuels
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.